Upregulation of sflt-1 by trophoblasts induces the barrier dysfunction of glomerular endothelial cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 6, 2011, Pages 815-818

  Zhao, Jun ^a   Liu, Haiyi ^a   Du, Hui ^a   Qiao, Fuyuan ^a   Li, Yvqi ^a   Shi, Xinwei ^a   Gong, Xun ^a   Wu, Yuanyuan ^a   Zhou, Qiong ^a   Xu, Jingjing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Glomerular endothelial cell; Monolayer barrier function; Preeclampsia; Trophoblast

Indexed keywords

FLT1 PROTEIN, HUMAN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CELL LINE; CYTOLOGY; ENDOTHELIUM CELL; FEMALE; GENETICS; GLOMERULUS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREECLAMPSIA; PREGNANCY; TROPHOBLAST; UPREGULATION;

CELL LINE; ENDOTHELIAL CELLS; FEMALE; HUMANS; KIDNEY GLOMERULUS; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84862961855     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0682-y     Document Type: Article

References (20)

1. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ, 2005,330(7491):565
2. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol, 2007,18(8):2281-2284 (Pubitemid 47203843)
3. Henao DE, Saleem MA, Cadavid AP. Glomerular disturbances in preeclampsia: Disruption between glomerular endothelium and podocyte symbiosis. Hypertens Pregnancy, 2010,29(1):10-20
4. Moran P, Baylis PH, Lindheimer MD, et al. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol, 2003,14:648-652 (Pubitemid 36246008)
5. Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med, 2008,359(8):800-809
6. Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG, 2003,110(9):831-836 (Pubitemid 37159268)
7. Karumanchi SA, Stillman IE. In vivo rat model of preeclampsia. Methods Mol Med, 2006,122:393-399
8. Doi K, Noiri E, Fujita T. Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol, 2010,8(1):122-128
9. Tang Z, Ren H, Yang G, et al. Significance of vascular endothelial growth factor expression in renal tissue of patients with preeclamptic nephropathy. Am J Nephrol, 2005,25(6):579-585 (Pubitemid 41816051)
10. Wakelin SJ, Marson L, Howie SE, et al. The role of vascular endothelial growth factor in the kidney in health and disease. Nephron Physiol, 2004,98(3):73-79
11. Feng HC, Choy MY, Deng W, et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig, 2005,12:e21-e32 (Pubitemid 40615105)
12. Satchell SC, Tasman CH, Singh A, et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int, 2006,69(9):1633-1640
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001,25(4):402-408 (Pubitemid 34164012)
14. Du H, Liu HY, Zhao J, et al. Effects of maternal serum on permeability of glomerular endothelial cell membrane. J Huazhong Univ Sci Technol [Med Sci], 2011,31(1):17-20
15. Zhou Q, Liu HY, Qiao FY, et al. VEGF deficit is involved in endothelium dysfunction in preeclampsia. J Huazhong Univ Sci Technol [Med Sci], 2010,30(3): 370-374
16. Zhou Q, Qiao FY, Zhao C, et al. Hypoxic trophoblast- derived sFlt-1 may contribute to endothelial dysfunction: An implication for the mechanism of trophoblast- endothelial dysfunction in preeclampsia. Cell Biol Int, 2011,35(1):61-66
17. Leeuwis JW, Nguyen TQ, Dendooven A, et al. Targeting podocyte-associated diseases. Adv Drug Deliv Rev, 2010,62(14):1325-1336
18. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004,350(7):672-683 (Pubitemid 38364626)
19. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest, 2003,111(5):649-658 (Pubitemid 36278583)
20. Li Z, Zhang Y, Ying Ma J, et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension, 2007,50:686-692 (Pubitemid 47442732)